Coty Inc
COTY
2.80
+0.01
+0.36%
Coty Inc
US · COTY
#2662 by market cap
Listed 1970
2.80
+0.01
+0.36%
Live - 5344 symbols - heartbeat 115s ago
· 2026-10-08 08:09
Pre-market
2.80
0.00%
After-hours
2.85
+1.79%
Overnight
2.77
-1.07%
- Market cap
- 2.47B
- P/E (TTM)i
- -4.00
- P/Bi
- 0.82
- EPSi
- -0.70
- Div yieldi
- 0.00%
- 52W posi
- 38%
Reader sentiment
Are you bullish or bearish on COTY?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is -0.00, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -1.46% YoY
Margins
- Gross margin
- 62.89%
- Operating margin
- 4.86%
- Net margin
- -10.64%
Key ratios & quality
- Enterprise valuei
- 5.40B
- Altman Z-Scorei
- 0.00
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.29B | 4.72B | 4.63B | 5.30B | 5.55B | 6.12B | 5.89B | 5.81B |
| Gross profit | 3.79B | 2.73B | 2.77B | 3.37B | 3.55B | 3.94B | 3.82B | 3.65B |
| Selling & admin expenses | 3.47B | 3.12B | 2.36B | 2.88B | 2.82B | 3.16B | 3.10B | 3.11B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 74.80M | -626.50M | 153.80M | 280.50M | 537.20M | 583.40M | 530.60M | 282.10M |
| Pretax profit | -3.95B | -1.47B | -239.80M | 426.80M | 704.80M | 204.50M | -344.80M | -610.20M |
| Tax | -54.80M | -377.70M | -172.00M | 164.80M | 181.60M | 95.10M | 5.40M | -20.00M |
| Net profit | -3.77B | -1.00B | -205.10M | 267.70M | 523.20M | 109.40M | -350.20M | -590.20M |
| Basic EPS | -5 | -1 | 0 | 0 | 1 | 0 | 0 | -1 |
| Diluted EPS | -5.04 | -1.33 | -0.40 | 0.08 | 0.57 | 0.09 | -0.44 | -0.70 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.30B | 1.25B | 1.58B | 1.68B | 1.28B | 1.27B |
| Gross profit | 832.40M | 779.70M | 1.02B | 1.07B | 791.90M | 772.70M |
| Selling & admin expenses | 777.50M | 720.60M | 793.50M | 842.50M | 727.00M | 744.90M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 9.00M | 13.50M | 184.00M | 154.00M | -9.60M | -46.30M |
| Pretax profit | -460.60M | -73.50M | 107.10M | -168.60M | -458.90M | -89.80M |
| Tax | -58.40M | -4.20M | 33.10M | -52.40M | -53.20M | 52.50M |
| Net profit | -402.20M | -69.30M | 74.00M | -116.20M | -405.70M | -142.30M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.47 | -0.08 | 0.07 | -0.14 | -0.47 | -0.16 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.27B | 6.50B | 1.78B | 1.68B | 2.05B | 1.96B | 1.95B | 1.92B |
| Cash & ST investments | 340.40M | 308.30M | 253.50M | 233.30M | 246.90M | 300.80M | 257.10M | 176.10M |
| Inventory | 860.10M | 678.20M | 650.80M | 661.50M | 853.40M | 764.10M | 794.50M | 838.70M |
| Total assets | 17.71B | 16.73B | 13.69B | 12.12B | 12.66B | 12.08B | 11.91B | 10.20B |
| Total current liabilities | 3.48B | 3.59B | 2.42B | 2.57B | 2.74B | 2.60B | 2.54B | 2.54B |
| Short-term debt | 193.80M | 293.30M | 125.70M | 90.80M | 123.50M | 60.80M | 67.90M | 79.60M |
| Long-term debt | 7.47B | 7.89B | 5.40B | 4.41B | 4.18B | 3.84B | 3.96B | 3.03B |
| Total liabilities | 12,664,800,000.00 | 12,705,100,000.00 | 9,508,800,000.00 | 8,558,100,000.00 | 8,428,300,000.00 | 7,834,800,000.00 | 7,952,100,000.00 | 6,821,300,000.00 |
| Total equity | 5.05B | 4.02B | 4.18B | 3.56B | 4.23B | 4.25B | 3.96B | 3.38B |
| Retained earnings | -4.54B | -5.55B | -5.76B | -5.50B | -4.99B | -4.90B | -5.27B | -5.88B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.93B | 1.95B | 2.17B | 2.25B | 1.94B | 1.92B |
| Cash & ST investments | 243.50M | 257.10M | 264.60M | 436.70M | 257.10M | 176.10M |
| Inventory | 717.30M | 794.50M | 807.50M | 778.20M | 786.30M | 838.70M |
| Total assets | 11.47B | 11.91B | 12.06B | 11.08B | 10.23B | 10.20B |
| Total current liabilities | 2.36B | 2.54B | 2.55B | 2.84B | 2.36B | 2.54B |
| Short-term debt | 68.00M | 67.90M | 66.70M | 67.40M | 65.80M | 79.60M |
| Long-term debt | 3.80B | 3.96B | 4.02B | 2.99B | 3.17B | 3.03B |
| Total liabilities | 7,551,000,000.00 | 7,952,100,000.00 | 8,003,000,000.00 | 7,132,400,000.00 | 6,727,200,000.00 | 6,821,300,000.00 |
| Total equity | 3.92B | 3.96B | 4.06B | 3.94B | 3.50B | 3.38B |
| Retained earnings | -5.20B | -5.27B | -5.20B | -5.33B | -5.74B | -5.88B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 639.60M | -50.90M | 318.70M | 726.60M | 625.70M | 614.60M | 492.60M | 537.80M |
| Depreciation & amortization | 736.00M | 716.50M | 585.30M | 516.40M | 426.70M | 421.10M | 420.00M | 482.20M |
| Free cash flow | 213.00M | -318.30M | 144.80M | 552.50M | 402.90M | 369.40M | 277.60M | 348.20M |
| Dividends paid | -346.20M | -196.90M | -25.70M | -57.20M | -13.70M | -13.40M | -13.30M | -13.20M |
| Stock buybacks / issuance | 5.90M | -- | 227.20M | 0 | 900.00K | 355.90M | 0 | 0 |
| Ending cash balance | 380.40M | 352.00M | 310.40M | 263.80M | 283.80M | 320.60M | 270.40M | 188.90M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -122.50M | 83.20M | 65.20M | 559.70M | -203.10M | 116.00M |
| Depreciation & amortization | 105.10M | 104.70M | 94.90M | 130.10M | 129.10M | 128.10M |
| Free cash flow | -168.40M | 34.90M | 11.20M | 513.10M | -248.70M | 72.60M |
| Dividends paid | -3.20M | -3.40M | -3.30M | -3.30M | -3.30M | -3.30M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 259.40M | 270.40M | 273.10M | 448.00M | 270.20M | 188.90M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -56.33 | -26.69 | -10.35 | 2.03 | 14.21 | 2.00 | -10.34 | -18.92 |
| ROA %i | -18.78 | -5.89 | -2.00 | 0.47 | 4.00 | 0.62 | -3.18 | -5.59 |
| ROIC %i | -24.46 | -7.10 | -1.36 | 2.47 | 8.31 | 3.08 | -2.85 | -6.50 |
| 5-year avg ROE %i | -3.54 | -14.00 | -20.79 | -18.64 | -15.43 | -3.76 | -0.49 | -2.20 |
| EBIT margin %i | -40.19 | -26.16 | -0.17 | 12.59 | 17.39 | 7.46 | -2.00 | -7.34 |
| FCF / sales %i | 2.46 | -- | 3.13 | 10.42 | 7.25 | 6.04 | 4.71 | 6.00 |
| Current ratioi | 0.94 | 1.81 | 0.74 | 0.66 | 0.75 | 0.75 | 0.77 | 0.75 |
| Quick ratioi | 0.41 | 0.28 | 0.39 | 0.33 | 0.31 | 0.36 | 0.31 | 0.28 |
| Debt / assetsi | 43.27 | 50.83 | 42.33 | 39.47 | 35.93 | 34.11 | 35.65 | 32.31 |
| LT debt / equityi | 162.86 | 273.23 | 198.21 | 148.72 | 116.13 | 106.10 | 117.91 | 107.58 |
| Interest coveragei | -11.49 | -5.29 | -0.03 | 2.77 | 3.70 | 1.81 | -0.52 | -2.31 |
| Revenue CAGR (3Y) %i | 13.08 | -14.88 | -12.21 | -5.51 | 5.59 | 9.74 | 3.57 | 1.49 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -15.36 | -- | -- | 37.40 | -- | 36.64 | -20.50 | -4.75 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -10.93 | -10.34 | -10.30 | -14.86 | -16.57 | -18.92 |
| ROA %i | -3.44 | -3.18 | -3.22 | -4.77 | -5.03 | -5.59 |
| ROIC %i | -2.46 | -2.85 | -2.43 | -5.27 | -5.46 | -6.50 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -2.45 | -2.00 | -2.62 | -6.57 | -7.07 | -7.34 |
| FCF / sales %i | 5.99 | 4.71 | 5.15 | 6.73 | 5.36 | 6.00 |
| Current ratioi | 0.82 | 0.77 | 0.85 | 0.79 | 0.82 | 0.75 |
| Quick ratioi | 0.35 | 0.31 | 0.40 | 0.40 | 0.35 | 0.28 |
| Debt / assetsi | 35.65 | 35.65 | 35.64 | 29.46 | 33.48 | 32.31 |
| LT debt / equityi | 115.05 | 117.91 | 116.13 | 90.63 | 108.66 | 107.58 |
| Interest coveragei | -0.64 | -0.52 | -0.70 | -1.78 | -2.22 | -2.31 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Prestige is the largest reported line at 65.54% of revenue, across 2 reported segments.
- Consumer Beauty follows at 34.46%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Prestige65.54%
Consumer Beauty34.46%
Region
Other75.35%
U.S.24.65%
Quote time 2026-10-08 08:09:28 · For reference only, not investment advice and not tailored to your situation.